Alcon AG reported 51.53 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
AstraZeneca 24.63 0.71 Sep/2026
Bayer 4.61 0.47 Sep/2026
Essilor 61.39 7.22 Jun/2026
Fresenius 14.02 2.58 Sep/2026
Fresenius Medical Care 8.23 3.9 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
GRIFOLS 13.04 1.66 Sep/2026
Lonza 34.34 2.58 Dec/2025
Merck 17.21 4.47 Jun/2026
Novartis 19.17 3.24 Sep/2026
Philips 18.8 4.96 Sep/2026
Roche Holding 16.48 0.39 Jun/2026
Sanofi 22.34 3.38 Sep/2026
Smith & Nephew 13.76 3.86 Jun/2026
Sonova Holding 25.61 4.39 Jun/2025
UCB 29.7 5.52 Dec/2025